| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Center for Neurologic Diseases, Harvard Institutes of Medicine, Brigham and Women’s Hospital, Boston, MA 02115;
Laboratory Service, Veterans Affairs Medical Center, Palo Alto, CA 94304; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305;
Department of Pharmacology, Merck Research Laboratories, Rahway, NJ 07065; and
Juvenile Diabetes Research Foundation/Wellcome Trust, Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom
Linkage analysis and congenic mapping in NOD mice have identified a susceptibility locus for type 1 diabetes, Idd5.1 on mouse chromosome 1, which includes the Ctla4 and Icos genes. Besides type 1 diabetes, numerous autoimmune diseases have been mapped to a syntenic region on human chromosome 2q33. In this study we determined how the costimulatory molecules encoded by these genes contribute to the immunopathogenesis of experimental autoimmune encephalomyelitis (EAE). When we compared levels of expression of costimulatory molecules on T cells, we found higher ICOS and lower full-length CTLA-4 expression on activated NOD T cells compared with C57BL/6 (B6) and C57BL/10 (B10) T cells. Using NOD.B10 Idd5 congenic strains, we determined that a 2.1-Mb region controls the observed expression differences of ICOS. Although Idd5.1 congenic mice are resistant to diabetes, we found them more susceptible to myelin oligodendrocyte glycoprotein 35–55-induced EAE compared with NOD mice. Our data demonstrate that higher ICOS expression correlates with more IL-10 production by NOD-derived T cells, and this may be responsible for the less severe EAE in NOD mice compared with Idd5.1 congenic mice. Paradoxically, alleles at the Idd5.1 locus have opposite effects on two autoimmune diseases, diabetes and EAE. This may reflect differential roles for costimulatory pathways in inducing autoimmune responses depending upon the origin (tissue) of the target Ag.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  J. M. Rojo, E. Pini, G. Ojeda, R. Bello, C. Dong, R. A. Flavell, U. Dianzani, and P. Portoles CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo' Int. Immunol., April 1, 2008; 20(4): 577 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Greve, R. Simonenko, Z. Illes, A. Peterfalvi, N. Hamdi, M. P Mycko, K. W Selmaj, C. Rozsa, K. Rajczy, P. Bauer, et al. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland Multiple Sclerosis, March 1, 2008; 14(2): 153 - 158. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Hunter, D. Rainbow, V. Plagnol, J. A. Todd, L. B. Peterson, and L. S. Wicker Interactions between Idd5.1/Ctla4 and Other Type 1 Diabetes Genes J. Immunol., December 15, 2007; 179(12): 8341 - 8349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Maier, D. E. Anderson, P. L. De Jager, L. S. Wicker, and D. A. Hafler Allelic variant in CTLA4 alters T cell phosphorylation patterns PNAS, November 20, 2007; 104(47): 18607 - 18612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ito, M. Yang, Y.-H. Wang, R. Lande, J. Gregorio, O. A Perng, X.-F. Qin, Y.-J. Liu, and M. Gilliet Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand J. Exp. Med., January 22, 2007; 204(1): 105 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Butty, M. Roy, P. Sabeti, W. Besse, C. Benoist, and D. Mathis Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes PNAS, January 9, 2007; 104(2): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhu, I. Guleria, A. Khosroshahi, T. Chitnis, J. Imitola, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis J. Immunol., March 15, 2006; 176(6): 3480 - 3489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lundholm, V. Motta, A. Lofgren-Burstrom, N. Duarte, M.-L. Bergman, S. Mayans, and D. Holmberg Defective Induction of CTLA-4 in the NOD Mouse Is Controlled by the NOD Allele of Idd3/IL-2 and a Novel Locus (Ctex) Telomeric on Chromosome 1 Diabetes, February 1, 2006; 55(2): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Shilling, J. M. Pinto, D. C. Decker, D. H. Schneider, H. S. Bandukwala, J. R. Schneider, B. Camoretti-Mercado, C. Ober, and A. I. Sperling Cutting Edge: Polymorphisms in the ICOS Promoter Region Are Associated with Allergic Sensitization and Th2 Cytokine Production J. Immunol., August 15, 2005; 175(4): 2061 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Martinez, H. T. C. Kreuwel, W. L. Redmond, R. Trenney, K. Hunter, H. Rosen, N. Sarvetnick, L. S. Wicker, and L. A. Sherman CD8+ T Cell Tolerance in Nonobese Diabetic Mice Is Restored by Insulin-Dependent Diabetes Resistance Alleles J. Immunol., August 1, 2005; 175(3): 1677 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Mazon Pelaez, S. Vogler, U. Strauss, P. Wernhoff, J. Pahnke, G. Brockmann, H. Moch, H.-J. Thiesen, A. Rolfs, and S. M. Ibrahim Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease Hum. Mol. Genet., July 15, 2005; 14(14): 1977 - 1989. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
